HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE COVER ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a letter to the editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Miller, B. A. Articles by Hankey, B. F. Search for Related Content PubMed PubMed Citation Articles by Miller, B. A. Articles by Hankey, B. F.

CA: A Cancer Journal for Clinicians, Vol 43, Issue 1 27-41, Copyright © 1993 by American Cancer Society

ARTICLES

Recent incidence trends for breast cancer in women and the relevance of early detection: an update

B. A. Miller, E. J. Feuer and B. F. Hankey
Cancer Statistics Branch, National Cancer Institute, Bethesda, Maryland 20892.

The incidence of breast cancer in women has been rising dramatically in the United States since 1982, based on data collected by the Surveillance, Epidemiology, and End Results (SEER) program of the National Cancer Institute. An additional three years of incidence and mortality data are included in this update of the earlier analyses; however, the focus of this report remains on examining the steeply increasing incidence trend between 1982 and 1986. Over this period, incidence rates for in situ and localized invasive tumors increased among women age 50 and older, while rates for regional and distant tumors remained stable. The incidence of localized tumors less than 1.0, 1.0 to 1.9, and 2.0 to 2.9 cm in size increased more rapidly than that of tumors 3.0 cm and greater among women over age 50. Survival rates also improved among cases diagnosed over this time period. These descriptive data suggest that early detection may be playing a role in the recent increase in the incidence of breast cancer in women, although other factors cannot be ruled out. Conclusions regarding improved cancer control await confirmation by reduced breast cancer mortality.

This article has been cited by other articles:

				N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF]

				D. P. Cronin-Fenton, L. A. Ries, L. X. Clegg, and B. K. Edwards Rising Incidence Rates of Breast Carcinoma With Micrometastatic Lymph Node Involvement J Natl Cancer Inst, July 4, 2007; 99(13): 1044 - 1049. [Abstract] [Full Text] [PDF]

				I Blancas, J. Garcia-Puche, B Bermejo, E. Hanrahan, C Monteagudo, A Martinez-Agullo, R Rouzier, B. Hennessy, V Valero, and A Lluch Low number of examined lymph nodes in node-negative breast cancer patients is an adverse prognostic factor Ann. Onc., November 1, 2006; 17(11): 1644 - 1649. [Abstract] [Full Text] [PDF]

				M. Shinozaki, D. S.B. Hoon, A. E. Giuliano, N. M. Hansen, H.-J. Wang, R. Turner, and B. Taback Distinct Hypermethylation Profile of Primary Breast Cancer Is Associated with Sentinel Lymph Node Metastasis Clin. Cancer Res., March 15, 2005; 11(6): 2156 - 2162. [Abstract] [Full Text] [PDF]

				S. K. Chia, C. H. Speers, C. J. Bryce, M. M. Hayes, and I. A. Olivotto Ten-Year Outcomes in a Population-Based Cohort of Node-Negative, Lymphatic, and Vascular Invasion-Negative Early Breast Cancers Without Adjuvant Systemic Therapies J. Clin. Oncol., May 1, 2004; 22(9): 1630 - 1637. [Abstract] [Full Text] [PDF]

				L. A. Gloeckler Ries, M. E. Reichman, D. R. Lewis, B. F. Hankey, and B. K. Edwards Cancer Survival and Incidence from the Surveillance, Epidemiology, and End Results (SEER) Program Oncologist, December 1, 2003; 8(6): 541 - 552. [Abstract] [Full Text] [PDF]

				A. Ghafoor, A. Jemal, E. Ward, V. Cokkinides, R. Smith, and M. Thun Trends in Breast Cancer by Race and Ethnicity CA Cancer J Clin, November 1, 2003; 53(6): 342 - 355. [Abstract] [Full Text] [PDF]

				J.-P. Delille, P. J. Slanetz, E. D. Yeh, E. F. Halpern, D. B. Kopans, and L. Garrido Invasive Ductal Breast Carcinoma Response to Neoadjuvant Chemotherapy: Noninvasive Monitoring with Functional MR Imaging— Pilot Study Radiology, July 1, 2003; 228(1): 63 - 69. [Abstract] [Full Text] [PDF]

				D G R Evans, J M Birch, M Thorneycroft, G McGown, F Lalloo, and J M Varley Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome J. Med. Genet., December 1, 2002; 39(12): 941 - 944. [Full Text] [PDF]

				W. T. Yang, C. Metreweli, P. K. W. Lam, and J. Chang Benign and Malignant Breast Masses and Axillary Nodes: Evaluation with Echo-enhanced Color Power Doppler US Radiology, September 1, 2001; 220(3): 795 - 802. [Abstract] [Full Text] [PDF]

				K. C. Chu, R. E. Tarone, and O. W. Brawley Breast Cancer Trends of Black Women Compared With White Women Arch Fam Med, November 1, 1999; 8(6): 521 - 528. [Abstract] [Full Text] [PDF]

				M. Quinn and E. Allen Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening BMJ, November 25, 1995; 311(7017): 1391 - 1395. [Abstract] [Full Text]